Matches in Nanopublications for { ?s ?p "[Finally, results from pooled analyses of 4,048 MS cases also argue strongly that APOE epsilon status does not distinguish a relapsing-remitting from primary progressive disease course, or influence disease severity, as measured by the Expanded Disability Status Scale and disease duration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[Finally, results from pooled analyses of 4,048 MS cases also argue strongly that APOE epsilon status does not distinguish a relapsing-remitting from primary progressive disease course, or influence disease severity, as measured by the Expanded Disability Status Scale and disease duration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Finally, results from pooled analyses of 4,048 MS cases also argue strongly that APOE epsilon status does not distinguish a relapsing-remitting from primary progressive disease course, or influence disease severity, as measured by the Expanded Disability Status Scale and disease duration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP585039.RAN3KdMmcqfjrYYa_GLnxIt1_AyaNdHz4tqcIYd8PLoHA130_assertion description "[Finally, results from pooled analyses of 4,048 MS cases also argue strongly that APOE epsilon status does not distinguish a relapsing-remitting from primary progressive disease course, or influence disease severity, as measured by the Expanded Disability Status Scale and disease duration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585039.RAN3KdMmcqfjrYYa_GLnxIt1_AyaNdHz4tqcIYd8PLoHA130_provenance.
- NP548719.RAU7S_swxD4NB05bpG4Ck7xObA8_62N0qBpB0r9PzCZEM130_assertion description "[Finally, results from pooled analyses of 4,048 MS cases also argue strongly that APOE epsilon status does not distinguish a relapsing-remitting from primary progressive disease course, or influence disease severity, as measured by the Expanded Disability Status Scale and disease duration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548719.RAU7S_swxD4NB05bpG4Ck7xObA8_62N0qBpB0r9PzCZEM130_provenance.
- NP548717.RAiELTuXtCICt8dfqunHJ31HcVn5OCMSG9aSvtMz_crEE130_assertion description "[Finally, results from pooled analyses of 4,048 MS cases also argue strongly that APOE epsilon status does not distinguish a relapsing-remitting from primary progressive disease course, or influence disease severity, as measured by the Expanded Disability Status Scale and disease duration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548717.RAiELTuXtCICt8dfqunHJ31HcVn5OCMSG9aSvtMz_crEE130_provenance.
- NP246188.RAPWOIw4RAx3GB82A4vLsjtl_eSWUwRZHRaYiwGnZhbHo130_assertion description "[Finally, results from pooled analyses of 4,048 MS cases also argue strongly that APOE epsilon status does not distinguish a relapsing-remitting from primary progressive disease course, or influence disease severity, as measured by the Expanded Disability Status Scale and disease duration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246188.RAPWOIw4RAx3GB82A4vLsjtl_eSWUwRZHRaYiwGnZhbHo130_provenance.
- NP246630.RAFfNaLtD56R4Dy9mUm3aRee6by2iCZVE-iG6gkokrkGU130_assertion description "[Finally, results from pooled analyses of 4,048 MS cases also argue strongly that APOE epsilon status does not distinguish a relapsing-remitting from primary progressive disease course, or influence disease severity, as measured by the Expanded Disability Status Scale and disease duration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246630.RAFfNaLtD56R4Dy9mUm3aRee6by2iCZVE-iG6gkokrkGU130_provenance.